Table 2. Effect of the flippase recombination target (FRT) site number on CIGMC efficiency.
Integrated copy number | Number of strains | ||||
---|---|---|---|---|---|
GPF-1 | GPF-2 | GPF-3 | GPF-4 | GPF-5 | |
1 | 50 | 43 | 38 | 33 | 28 |
2 | 40 | 43 | 45 | 32 | 38 |
3 | 36 | 24 | 28 | 26 | 21 |
4 | 16 | 23 | 16 | 25 | 19 |
5 | 8 | 10 | 8 | 13 | 10 |
6 | Nda | 4 | 6 | 9 | 12 |
7 | Nd | 3 | 4 | 4 | 6 |
8 | Nd | Nd | 3 | 3 | 4 |
9 | Nd | Nd | 2 | 3 | 5 |
10 | Nd | Nd | Nd | 2 | 2 |
11 | Nd | Nd | Nd | Nd | 2 |
12 | Nd | Nd | Nd | Nd | 3 |
Average integrated copy number | 2.28 | 2.59 | 2.81 | 3.29 | 3.75 |
For each target strain, 150 clones were randomly selected to determine the integrated copy number of pG-2. The final concentration of pG-2 was 20 ng/μL.
aNot detected.